nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—PIK3CD—ovarian cancer	0.173	0.315	CbGaD
Caffeine—PIK3CB—ovarian cancer	0.173	0.315	CbGaD
Caffeine—PIK3CA—ovarian cancer	0.134	0.243	CbGaD
Caffeine—CYP1B1—ovarian cancer	0.0545	0.099	CbGaD
Caffeine—CYP1B1—Paclitaxel—ovarian cancer	0.0334	0.16	CbGbCtD
Caffeine—CYP1B1—Docetaxel—ovarian cancer	0.0242	0.116	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—ovarian cancer	0.018	0.0864	CbGbCtD
Caffeine—ABCB1—ovarian cancer	0.0156	0.0284	CbGaD
Caffeine—CYP3A7—Paclitaxel—ovarian cancer	0.0117	0.0563	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0117	0.0563	CbGbCtD
Caffeine—ABCB1—Topotecan—ovarian cancer	0.0116	0.0555	CbGbCtD
Caffeine—CYP3A5—Paclitaxel—ovarian cancer	0.0088	0.0422	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.00848	0.0407	CbGbCtD
Caffeine—CYP3A7—Docetaxel—ovarian cancer	0.00848	0.0407	CbGbCtD
Caffeine—CYP2C8—Paclitaxel—ovarian cancer	0.00846	0.0406	CbGbCtD
Caffeine—ABCB1—Vinorelbine—ovarian cancer	0.00815	0.0391	CbGbCtD
Caffeine—CYP2D6—Vinorelbine—ovarian cancer	0.00768	0.0369	CbGbCtD
Caffeine—Infusion site inflammation—Paclitaxel—ovarian cancer	0.00699	0.119	CcSEcCtD
Caffeine—CYP3A4—Topotecan—ovarian cancer	0.00693	0.0333	CbGbCtD
Caffeine—CYP3A5—Docetaxel—ovarian cancer	0.00636	0.0305	CbGbCtD
Caffeine—CYP2C9—Paclitaxel—ovarian cancer	0.0059	0.0283	CbGbCtD
Caffeine—ABCB1—Paclitaxel—ovarian cancer	0.00573	0.0275	CbGbCtD
Caffeine—CYP3A4—Vinorelbine—ovarian cancer	0.00488	0.0234	CbGbCtD
Caffeine—ABCB1—Docetaxel—ovarian cancer	0.00414	0.0199	CbGbCtD
Caffeine—Necrotising enterocolitis neonatal—Paclitaxel—ovarian cancer	0.00355	0.0602	CcSEcCtD
Caffeine—Necrotizing enterocolitis—Paclitaxel—ovarian cancer	0.00355	0.0602	CcSEcCtD
Caffeine—CYP3A4—Paclitaxel—ovarian cancer	0.00343	0.0165	CbGbCtD
Caffeine—ABCB1—Doxorubicin—ovarian cancer	0.00309	0.0148	CbGbCtD
Caffeine—Necrotizing enterocolitis—Docetaxel—ovarian cancer	0.00301	0.051	CcSEcCtD
Caffeine—Necrotising enterocolitis neonatal—Docetaxel—ovarian cancer	0.00301	0.051	CcSEcCtD
Caffeine—CYP2D6—Doxorubicin—ovarian cancer	0.00291	0.014	CbGbCtD
Caffeine—Necrotising colitis—Paclitaxel—ovarian cancer	0.0029	0.0492	CcSEcCtD
Caffeine—CYP3A4—Docetaxel—ovarian cancer	0.00248	0.0119	CbGbCtD
Caffeine—Necrotising colitis—Docetaxel—ovarian cancer	0.00246	0.0417	CcSEcCtD
Caffeine—PIK3CB—Irinotecan—Topotecan—ovarian cancer	0.00227	0.837	CbGdCrCtD
Caffeine—CYP3A4—Doxorubicin—ovarian cancer	0.00185	0.00888	CbGbCtD
Caffeine—Necrotising colitis—Epirubicin—ovarian cancer	0.00166	0.0281	CcSEcCtD
Caffeine—Necrotising colitis—Doxorubicin—ovarian cancer	0.00154	0.026	CcSEcCtD
Caffeine—ATM—embryo—ovarian cancer	0.00133	0.0227	CbGeAlD
Caffeine—Impaired healing—Melphalan—ovarian cancer	0.00132	0.0223	CcSEcCtD
Caffeine—PRKDC—myometrium—ovarian cancer	0.00131	0.0223	CbGeAlD
Caffeine—PIK3CD—embryo—ovarian cancer	0.00118	0.0202	CbGeAlD
Caffeine—ATM—epithelium—ovarian cancer	0.00109	0.0185	CbGeAlD
Caffeine—ATM—uterine cervix—ovarian cancer	0.00108	0.0184	CbGeAlD
Caffeine—PIK3CB—myometrium—ovarian cancer	0.00107	0.0183	CbGeAlD
Caffeine—RYR1—myometrium—ovarian cancer	0.00106	0.0181	CbGeAlD
Caffeine—PIK3CA—myometrium—ovarian cancer	0.00106	0.0181	CbGeAlD
Caffeine—PIK3CB—embryo—ovarian cancer	0.00103	0.0176	CbGeAlD
Caffeine—ATM—decidua—ovarian cancer	0.00103	0.0175	CbGeAlD
Caffeine—PIK3CA—embryo—ovarian cancer	0.00102	0.0174	CbGeAlD
Caffeine—PRKDC—uterine cervix—ovarian cancer	0.00102	0.0174	CbGeAlD
Caffeine—PRKDC—decidua—ovarian cancer	0.000973	0.0166	CbGeAlD
Caffeine—PIK3CD—epithelium—ovarian cancer	0.000966	0.0164	CbGeAlD
Caffeine—PRKDC—endometrium—ovarian cancer	0.000924	0.0157	CbGeAlD
Caffeine—PIK3CD—decidua—ovarian cancer	0.000913	0.0155	CbGeAlD
Caffeine—ATM—uterus—ovarian cancer	0.0009	0.0153	CbGeAlD
Caffeine—PRKDC—uterus—ovarian cancer	0.000851	0.0145	CbGeAlD
Caffeine—PIK3CB—epithelium—ovarian cancer	0.000843	0.0143	CbGeAlD
Caffeine—PIK3CB—uterine cervix—ovarian cancer	0.000835	0.0142	CbGeAlD
Caffeine—PIK3CA—epithelium—ovarian cancer	0.000834	0.0142	CbGeAlD
Caffeine—PIK3CA—uterine cervix—ovarian cancer	0.000827	0.0141	CbGeAlD
Caffeine—ATM—female reproductive system—ovarian cancer	0.000809	0.0138	CbGeAlD
Caffeine—PIK3CB—decidua—ovarian cancer	0.000796	0.0135	CbGeAlD
Caffeine—Disseminated intravascular coagulation—Docetaxel—ovarian cancer	0.000794	0.0135	CcSEcCtD
Caffeine—PIK3CA—decidua—ovarian cancer	0.000788	0.0134	CbGeAlD
Caffeine—ATM—bone marrow—ovarian cancer	0.000764	0.013	CbGeAlD
Caffeine—PIK3CB—endometrium—ovarian cancer	0.000756	0.0129	CbGeAlD
Caffeine—PIK3CA—endometrium—ovarian cancer	0.000748	0.0127	CbGeAlD
Caffeine—ATM—female gonad—ovarian cancer	0.000736	0.0125	CbGeAlD
Caffeine—ATM—vagina—ovarian cancer	0.000732	0.0125	CbGeAlD
Caffeine—PRKDC—bone marrow—ovarian cancer	0.000722	0.0123	CbGeAlD
Caffeine—PIK3CD—female reproductive system—ovarian cancer	0.000718	0.0122	CbGeAlD
Caffeine—PIK3CB—gonad—ovarian cancer	0.000701	0.0119	CbGeAlD
Caffeine—Convulsion—Altretamine—ovarian cancer	0.000696	0.0118	CcSEcCtD
Caffeine—PIK3CB—uterus—ovarian cancer	0.000696	0.0119	CbGeAlD
Caffeine—PRKDC—female gonad—ovarian cancer	0.000696	0.0119	CbGeAlD
Caffeine—PIK3CA—gonad—ovarian cancer	0.000694	0.0118	CbGeAlD
Caffeine—PRKDC—vagina—ovarian cancer	0.000692	0.0118	CbGeAlD
Caffeine—RYR1—uterus—ovarian cancer	0.000689	0.0117	CbGeAlD
Caffeine—PIK3CA—uterus—ovarian cancer	0.000689	0.0117	CbGeAlD
Caffeine—PIK3CD—bone marrow—ovarian cancer	0.000678	0.0115	CbGeAlD
Caffeine—ATM—testis—ovarian cancer	0.000653	0.0111	CbGeAlD
Caffeine—PIK3CD—female gonad—ovarian cancer	0.000653	0.0111	CbGeAlD
Caffeine—PIK3CB—female reproductive system—ovarian cancer	0.000626	0.0107	CbGeAlD
Caffeine—RYR1—female reproductive system—ovarian cancer	0.00062	0.0105	CbGeAlD
Caffeine—PIK3CA—female reproductive system—ovarian cancer	0.00062	0.0105	CbGeAlD
Caffeine—PRKDC—testis—ovarian cancer	0.000618	0.0105	CbGeAlD
Caffeine—PIK3CB—bone marrow—ovarian cancer	0.000591	0.0101	CbGeAlD
Caffeine—PIK3CA—bone marrow—ovarian cancer	0.000585	0.00995	CbGeAlD
Caffeine—ADORA2B—decidua—ovarian cancer	0.00058	0.00986	CbGeAlD
Caffeine—PIK3CD—testis—ovarian cancer	0.000579	0.00986	CbGeAlD
Caffeine—PIK3CB—female gonad—ovarian cancer	0.00057	0.00969	CbGeAlD
Caffeine—PIK3CB—vagina—ovarian cancer	0.000566	0.00964	CbGeAlD
Caffeine—PIK3CA—female gonad—ovarian cancer	0.000564	0.00959	CbGeAlD
Caffeine—RYR1—vagina—ovarian cancer	0.00056	0.00954	CbGeAlD
Caffeine—PIK3CA—vagina—ovarian cancer	0.00056	0.00954	CbGeAlD
Caffeine—Creatinine increased—Vinorelbine—ovarian cancer	0.000523	0.00886	CcSEcCtD
Caffeine—PIK3CB—testis—ovarian cancer	0.000505	0.0086	CbGeAlD
Caffeine—Sepsis—Topotecan—ovarian cancer	0.000505	0.00855	CcSEcCtD
Caffeine—PIK3CA—testis—ovarian cancer	0.0005	0.00851	CbGeAlD
Caffeine—RYR1—testis—ovarian cancer	0.0005	0.00851	CbGeAlD
Caffeine—ATM—lymph node—ovarian cancer	0.000473	0.00806	CbGeAlD
Caffeine—Infection—Carboplatin—ovarian cancer	0.00045	0.00763	CcSEcCtD
Caffeine—PRKDC—lymph node—ovarian cancer	0.000448	0.00762	CbGeAlD
Caffeine—Pulmonary oedema—Vinorelbine—ovarian cancer	0.000443	0.00751	CcSEcCtD
Caffeine—PRKDC—Vinblastine—Vinorelbine—ovarian cancer	0.000443	0.163	CbGdCrCtD
Caffeine—Sepsis—Vinorelbine—ovarian cancer	0.000432	0.00732	CcSEcCtD
Caffeine—ADORA2A—gonad—ovarian cancer	0.000425	0.00723	CbGeAlD
Caffeine—PIK3CD—lymph node—ovarian cancer	0.00042	0.00715	CbGeAlD
Caffeine—Haemoglobin decreased—Docetaxel—ovarian cancer	0.000412	0.00699	CcSEcCtD
Caffeine—ADORA2B—vagina—ovarian cancer	0.000412	0.00702	CbGeAlD
Caffeine—Deafness—Vinorelbine—ovarian cancer	0.000404	0.00684	CcSEcCtD
Caffeine—ADORA2A—female reproductive system—ovarian cancer	0.000379	0.00646	CbGeAlD
Caffeine—Accidental injury—Paclitaxel—ovarian cancer	0.000378	0.00641	CcSEcCtD
Caffeine—ADORA2B—testis—ovarian cancer	0.000368	0.00626	CbGeAlD
Caffeine—PIK3CB—lymph node—ovarian cancer	0.000366	0.00623	CbGeAlD
Caffeine—PIK3CA—lymph node—ovarian cancer	0.000362	0.00617	CbGeAlD
Caffeine—Blood creatinine increased—Vinorelbine—ovarian cancer	0.000338	0.00573	CcSEcCtD
Caffeine—ADORA1—female reproductive system—ovarian cancer	0.000327	0.00557	CbGeAlD
Caffeine—Infestation—Topotecan—ovarian cancer	0.000325	0.00551	CcSEcCtD
Caffeine—Infestation NOS—Topotecan—ovarian cancer	0.000325	0.00551	CcSEcCtD
Caffeine—PDE4B—uterine cervix—ovarian cancer	0.000323	0.0055	CbGeAlD
Caffeine—PDE4B—decidua—ovarian cancer	0.000308	0.00524	CbGeAlD
Caffeine—ADORA2A—testis—ovarian cancer	0.000306	0.00521	CbGeAlD
Caffeine—Urine output increased—Paclitaxel—ovarian cancer	0.000303	0.00513	CcSEcCtD
Caffeine—ADORA1—vagina—ovarian cancer	0.000296	0.00504	CbGeAlD
Caffeine—Haemoglobin—Topotecan—ovarian cancer	0.000294	0.00498	CcSEcCtD
Caffeine—Theophylline—CYP1B1—ovarian cancer	0.000294	1	CrCbGaD
Caffeine—PDE4B—endometrium—ovarian cancer	0.000292	0.00498	CbGeAlD
Caffeine—Haemorrhage—Topotecan—ovarian cancer	0.000292	0.00495	CcSEcCtD
Caffeine—Sepsis—Paclitaxel—ovarian cancer	0.00029	0.00492	CcSEcCtD
Caffeine—Haemoglobin—Melphalan—ovarian cancer	0.000288	0.00487	CcSEcCtD
Caffeine—Haemorrhage—Melphalan—ovarian cancer	0.000286	0.00485	CcSEcCtD
Caffeine—Infestation NOS—Vinorelbine—ovarian cancer	0.000278	0.00472	CcSEcCtD
Caffeine—Infestation—Vinorelbine—ovarian cancer	0.000278	0.00472	CcSEcCtD
Caffeine—Hypercalcaemia—Epirubicin—ovarian cancer	0.000275	0.00467	CcSEcCtD
Caffeine—Deafness—Paclitaxel—ovarian cancer	0.000272	0.0046	CcSEcCtD
Caffeine—PDE4B—gonad—ovarian cancer	0.000271	0.00462	CbGeAlD
Caffeine—Injury—Paclitaxel—ovarian cancer	0.000264	0.00448	CcSEcCtD
Caffeine—ADORA1—testis—ovarian cancer	0.000264	0.0045	CbGeAlD
Caffeine—CYP1B1—decidua—ovarian cancer	0.000264	0.00449	CbGeAlD
Caffeine—Immune system disorder—Topotecan—ovarian cancer	0.000264	0.00447	CcSEcCtD
Caffeine—Agitation—Chlorambucil—ovarian cancer	0.000263	0.00445	CcSEcCtD
Caffeine—Immune system disorder—Melphalan—ovarian cancer	0.000258	0.00438	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—ovarian cancer	0.000255	0.00432	CcSEcCtD
Caffeine—Malnutrition—Topotecan—ovarian cancer	0.000254	0.00431	CcSEcCtD
Caffeine—Pulmonary oedema—Docetaxel—ovarian cancer	0.000253	0.00428	CcSEcCtD
Caffeine—Hypoglycaemia—Paclitaxel—ovarian cancer	0.000249	0.00422	CcSEcCtD
Caffeine—Convulsion—Chlorambucil—ovarian cancer	0.000248	0.00419	CcSEcCtD
Caffeine—Sepsis—Docetaxel—ovarian cancer	0.000246	0.00417	CcSEcCtD
Caffeine—PDE4B—female reproductive system—ovarian cancer	0.000242	0.00412	CbGeAlD
Caffeine—CYP1B1—gonad—ovarian cancer	0.000232	0.00396	CbGeAlD
Caffeine—Cardiac disorder—Vinorelbine—ovarian cancer	0.000232	0.00393	CcSEcCtD
Caffeine—Infection—Chlorambucil—ovarian cancer	0.000232	0.00392	CcSEcCtD
Caffeine—CYP1B1—uterus—ovarian cancer	0.000231	0.00393	CbGeAlD
Caffeine—Deafness—Docetaxel—ovarian cancer	0.00023	0.0039	CcSEcCtD
Caffeine—PDE4B—bone marrow—ovarian cancer	0.000229	0.00389	CbGeAlD
Caffeine—Blood creatinine increased—Paclitaxel—ovarian cancer	0.000228	0.00386	CcSEcCtD
Caffeine—Immune system disorder—Vinorelbine—ovarian cancer	0.000226	0.00383	CcSEcCtD
Caffeine—Dry skin—Paclitaxel—ovarian cancer	0.000223	0.00377	CcSEcCtD
Caffeine—PDE4B—female gonad—ovarian cancer	0.00022	0.00375	CbGeAlD
Caffeine—PDE4B—vagina—ovarian cancer	0.000219	0.00373	CbGeAlD
Caffeine—Malnutrition—Vinorelbine—ovarian cancer	0.000218	0.00369	CcSEcCtD
Caffeine—Convulsion—Melphalan—ovarian cancer	0.000216	0.00366	CcSEcCtD
Caffeine—CYP1B1—female reproductive system—ovarian cancer	0.000208	0.00353	CbGeAlD
Caffeine—Infection—Topotecan—ovarian cancer	0.000206	0.00349	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000206	0.00349	CcSEcCtD
Caffeine—Nervous system disorder—Topotecan—ovarian cancer	0.000204	0.00345	CcSEcCtD
Caffeine—Infection—Melphalan—ovarian cancer	0.000202	0.00342	CcSEcCtD
Caffeine—Skin disorder—Topotecan—ovarian cancer	0.000202	0.00342	CcSEcCtD
Caffeine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000201	0.00341	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—ovarian cancer	0.000201	0.00341	CcSEcCtD
Caffeine—Tachycardia—Melphalan—ovarian cancer	0.000198	0.00336	CcSEcCtD
Caffeine—CYP1A1—epithelium—ovarian cancer	0.000198	0.00336	CbGeAlD
Caffeine—Skin disorder—Melphalan—ovarian cancer	0.000197	0.00334	CcSEcCtD
Caffeine—CYP1A1—uterine cervix—ovarian cancer	0.000196	0.00333	CbGeAlD
Caffeine—PDE4B—testis—ovarian cancer	0.000195	0.00333	CbGeAlD
Caffeine—CYP2C8—endometrium—ovarian cancer	0.000192	0.00327	CbGeAlD
Caffeine—ADORA1—lymph node—ovarian cancer	0.000192	0.00326	CbGeAlD
Caffeine—CYP3A5—uterine cervix—ovarian cancer	0.000192	0.00326	CbGeAlD
Caffeine—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000189	0.00321	CcSEcCtD
Caffeine—CYP1B1—female gonad—ovarian cancer	0.000189	0.00322	CbGeAlD
Caffeine—Dry skin—Docetaxel—ovarian cancer	0.000189	0.0032	CcSEcCtD
Caffeine—Hypertension—Vinorelbine—ovarian cancer	0.000188	0.00318	CcSEcCtD
Caffeine—Infestation NOS—Paclitaxel—ovarian cancer	0.000187	0.00317	CcSEcCtD
Caffeine—Infestation—Paclitaxel—ovarian cancer	0.000187	0.00317	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—ovarian cancer	0.000186	0.00315	CcSEcCtD
Caffeine—Dyspnoea—Topotecan—ovarian cancer	0.000185	0.00314	CcSEcCtD
Caffeine—Renal failure—Paclitaxel—ovarian cancer	0.000184	0.00312	CcSEcCtD
Caffeine—Dyspnoea—Melphalan—ovarian cancer	0.000181	0.00307	CcSEcCtD
Caffeine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000179	0.00304	CcSEcCtD
Caffeine—Infection—Vinorelbine—ovarian cancer	0.000176	0.00299	CcSEcCtD
Caffeine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000175	0.00297	CcSEcCtD
Caffeine—Nervous system disorder—Vinorelbine—ovarian cancer	0.000174	0.00295	CcSEcCtD
Caffeine—Tachycardia—Vinorelbine—ovarian cancer	0.000173	0.00294	CcSEcCtD
Caffeine—Skin disorder—Vinorelbine—ovarian cancer	0.000172	0.00292	CcSEcCtD
Caffeine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000172	0.00291	CcSEcCtD
Caffeine—Pulmonary oedema—Epirubicin—ovarian cancer	0.00017	0.00289	CcSEcCtD
Caffeine—Haemoglobin—Paclitaxel—ovarian cancer	0.000169	0.00286	CcSEcCtD
Caffeine—Haemorrhage—Paclitaxel—ovarian cancer	0.000168	0.00285	CcSEcCtD
Caffeine—CYP1B1—testis—ovarian cancer	0.000168	0.00285	CbGeAlD
Caffeine—Sepsis—Epirubicin—ovarian cancer	0.000166	0.00281	CcSEcCtD
Caffeine—CYP1A1—uterus—ovarian cancer	0.000163	0.00278	CbGeAlD
Caffeine—CYP2C8—female reproductive system—ovarian cancer	0.000159	0.00271	CbGeAlD
Caffeine—Infestation NOS—Docetaxel—ovarian cancer	0.000159	0.00269	CcSEcCtD
Caffeine—Infestation—Docetaxel—ovarian cancer	0.000159	0.00269	CcSEcCtD
Caffeine—Dyspnoea—Vinorelbine—ovarian cancer	0.000158	0.00268	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—ovarian cancer	0.000158	0.00267	CcSEcCtD
Caffeine—Renal failure—Docetaxel—ovarian cancer	0.000156	0.00264	CcSEcCtD
Caffeine—Cardiac disorder—Paclitaxel—ovarian cancer	0.000156	0.00264	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—ovarian cancer	0.000154	0.0026	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000153	0.0026	CcSEcCtD
Caffeine—Hypersensitivity—Topotecan—ovarian cancer	0.000153	0.00259	CcSEcCtD
Caffeine—Immune system disorder—Paclitaxel—ovarian cancer	0.000152	0.00257	CcSEcCtD
Caffeine—Hypersensitivity—Melphalan—ovarian cancer	0.00015	0.00254	CcSEcCtD
Caffeine—CYP1A1—female reproductive system—ovarian cancer	0.000147	0.0025	CbGeAlD
Caffeine—Malnutrition—Paclitaxel—ovarian cancer	0.000146	0.00248	CcSEcCtD
Caffeine—CYP2C8—vagina—ovarian cancer	0.000144	0.00245	CbGeAlD
Caffeine—Haemoglobin—Docetaxel—ovarian cancer	0.000143	0.00243	CcSEcCtD
Caffeine—Haemorrhage—Docetaxel—ovarian cancer	0.000142	0.00241	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—ovarian cancer	0.000142	0.00241	CcSEcCtD
Caffeine—Nervousness—Paclitaxel—ovarian cancer	0.000142	0.00241	CcSEcCtD
Caffeine—PDE4B—lymph node—ovarian cancer	0.000142	0.00241	CbGeAlD
Caffeine—CYP2C9—female reproductive system—ovarian cancer	0.000141	0.0024	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000139	0.00235	CcSEcCtD
Caffeine—Agitation—Paclitaxel—ovarian cancer	0.000134	0.00228	CcSEcCtD
Caffeine—CYP2E1—female reproductive system—ovarian cancer	0.000134	0.00228	CbGeAlD
Caffeine—CYP1A1—female gonad—ovarian cancer	0.000134	0.00227	CbGeAlD
Caffeine—CYP1A1—vagina—ovarian cancer	0.000133	0.00226	CbGeAlD
Caffeine—Cardiac disorder—Docetaxel—ovarian cancer	0.000132	0.00224	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000132	0.00223	CcSEcCtD
Caffeine—Rash—Topotecan—ovarian cancer	0.000131	0.00222	CcSEcCtD
Caffeine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000131	0.00222	CcSEcCtD
Caffeine—Dermatitis—Topotecan—ovarian cancer	0.000131	0.00222	CcSEcCtD
Caffeine—ABCB1—myometrium—ovarian cancer	0.000131	0.00223	CbGeAlD
Caffeine—CYP3A5—female gonad—ovarian cancer	0.000131	0.00222	CbGeAlD
Caffeine—Blood creatinine increased—Epirubicin—ovarian cancer	0.00013	0.00221	CcSEcCtD
Caffeine—CYP3A5—vagina—ovarian cancer	0.00013	0.00221	CbGeAlD
Caffeine—Immune system disorder—Docetaxel—ovarian cancer	0.000129	0.00218	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000129	0.00218	CcSEcCtD
Caffeine—CYP2C8—testis—ovarian cancer	0.000128	0.00218	CbGeAlD
Caffeine—Rash—Melphalan—ovarian cancer	0.000128	0.00217	CcSEcCtD
Caffeine—Dermatitis—Melphalan—ovarian cancer	0.000128	0.00217	CcSEcCtD
Caffeine—Dry skin—Epirubicin—ovarian cancer	0.000127	0.00216	CcSEcCtD
Caffeine—Convulsion—Paclitaxel—ovarian cancer	0.000127	0.00215	CcSEcCtD
Caffeine—Hypertension—Paclitaxel—ovarian cancer	0.000126	0.00214	CcSEcCtD
Caffeine—ABCB1—embryo—ovarian cancer	0.000126	0.00214	CbGeAlD
Caffeine—Malnutrition—Docetaxel—ovarian cancer	0.000124	0.0021	CcSEcCtD
Caffeine—Gastritis—Epirubicin—ovarian cancer	0.000123	0.00208	CcSEcCtD
Caffeine—CYP1B1—lymph node—ovarian cancer	0.000121	0.00207	CbGeAlD
Caffeine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00012	0.00204	CcSEcCtD
Caffeine—Infection—Paclitaxel—ovarian cancer	0.000119	0.00201	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—ovarian cancer	0.000118	0.002	CcSEcCtD
Caffeine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000117	0.00198	CcSEcCtD
Caffeine—Tachycardia—Paclitaxel—ovarian cancer	0.000117	0.00198	CcSEcCtD
Caffeine—Skin disorder—Paclitaxel—ovarian cancer	0.000116	0.00197	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—ovarian cancer	0.000114	0.00193	CcSEcCtD
Caffeine—Rash—Vinorelbine—ovarian cancer	0.000112	0.0019	CcSEcCtD
Caffeine—Dermatitis—Vinorelbine—ovarian cancer	0.000112	0.0019	CcSEcCtD
Caffeine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000108	0.00184	CcSEcCtD
Caffeine—CYP2E1—testis—ovarian cancer	0.000108	0.00184	CbGeAlD
Caffeine—CYP3A4—female reproductive system—ovarian cancer	0.000108	0.00183	CbGeAlD
Caffeine—Convulsion—Docetaxel—ovarian cancer	0.000107	0.00182	CcSEcCtD
Caffeine—Hypertension—Docetaxel—ovarian cancer	0.000107	0.00181	CcSEcCtD
Caffeine—Infestation—Epirubicin—ovarian cancer	0.000107	0.00181	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—ovarian cancer	0.000107	0.00181	CcSEcCtD
Caffeine—Dyspnoea—Paclitaxel—ovarian cancer	0.000106	0.0018	CcSEcCtD
Caffeine—CYP2D6—female reproductive system—ovarian cancer	0.000106	0.0018	CbGeAlD
Caffeine—Renal failure—Epirubicin—ovarian cancer	0.000105	0.00178	CcSEcCtD
Caffeine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000103	0.00175	CcSEcCtD
Caffeine—ABCB1—epithelium—ovarian cancer	0.000103	0.00175	CbGeAlD
Caffeine—ABCB1—uterine cervix—ovarian cancer	0.000102	0.00173	CbGeAlD
Caffeine—Infection—Docetaxel—ovarian cancer	0.000101	0.0017	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.0001	0.0017	CcSEcCtD
Caffeine—Nervous system disorder—Docetaxel—ovarian cancer	9.93e-05	0.00168	CcSEcCtD
Caffeine—Infestation—Doxorubicin—ovarian cancer	9.9e-05	0.00168	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—ovarian cancer	9.9e-05	0.00168	CcSEcCtD
Caffeine—Tachycardia—Docetaxel—ovarian cancer	9.88e-05	0.00167	CcSEcCtD
Caffeine—Skin disorder—Docetaxel—ovarian cancer	9.83e-05	0.00167	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—ovarian cancer	9.74e-05	0.00165	CcSEcCtD
Caffeine—ABCB1—decidua—ovarian cancer	9.69e-05	0.00165	CbGeAlD
Caffeine—Haemoglobin—Epirubicin—ovarian cancer	9.66e-05	0.00164	CcSEcCtD
Caffeine—CYP2D6—female gonad—ovarian cancer	9.64e-05	0.00164	CbGeAlD
Caffeine—Haemorrhage—Epirubicin—ovarian cancer	9.61e-05	0.00163	CcSEcCtD
Caffeine—ABCB1—endometrium—ovarian cancer	9.2e-05	0.00157	CbGeAlD
Caffeine—Dyspnoea—Docetaxel—ovarian cancer	9.02e-05	0.00153	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—ovarian cancer	8.94e-05	0.00151	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—ovarian cancer	8.92e-05	0.00151	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—ovarian cancer	8.89e-05	0.00151	CcSEcCtD
Caffeine—Hypersensitivity—Paclitaxel—ovarian cancer	8.8e-05	0.00149	CcSEcCtD
Caffeine—Gastrointestinal disorder—Docetaxel—ovarian cancer	8.74e-05	0.00148	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—ovarian cancer	8.68e-05	0.00147	CcSEcCtD
Caffeine—CYP1A1—lymph node—ovarian cancer	8.58e-05	0.00146	CbGeAlD
Caffeine—CYP2D6—testis—ovarian cancer	8.55e-05	0.00146	CbGeAlD
Caffeine—ABCB1—gonad—ovarian cancer	8.54e-05	0.00145	CbGeAlD
Caffeine—ABCB1—uterus—ovarian cancer	8.48e-05	0.00144	CbGeAlD
Caffeine—Malnutrition—Epirubicin—ovarian cancer	8.37e-05	0.00142	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—ovarian cancer	8.25e-05	0.0014	CcSEcCtD
Caffeine—Nervousness—Epirubicin—ovarian cancer	8.13e-05	0.00138	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—ovarian cancer	8.03e-05	0.00136	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—ovarian cancer	7.74e-05	0.00131	CcSEcCtD
Caffeine—Agitation—Epirubicin—ovarian cancer	7.69e-05	0.0013	CcSEcCtD
Caffeine—ABCB1—female reproductive system—ovarian cancer	7.62e-05	0.0013	CbGeAlD
Caffeine—Rash—Paclitaxel—ovarian cancer	7.53e-05	0.00128	CcSEcCtD
Caffeine—Dermatitis—Paclitaxel—ovarian cancer	7.52e-05	0.00127	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—ovarian cancer	7.52e-05	0.00127	CcSEcCtD
Caffeine—Hypersensitivity—Docetaxel—ovarian cancer	7.46e-05	0.00126	CcSEcCtD
Caffeine—Convulsion—Epirubicin—ovarian cancer	7.25e-05	0.00123	CcSEcCtD
Caffeine—Hypertension—Epirubicin—ovarian cancer	7.22e-05	0.00122	CcSEcCtD
Caffeine—ABCB1—bone marrow—ovarian cancer	7.2e-05	0.00122	CbGeAlD
Caffeine—Agitation—Doxorubicin—ovarian cancer	7.11e-05	0.00121	CcSEcCtD
Caffeine—ABCB1—female gonad—ovarian cancer	6.94e-05	0.00118	CbGeAlD
Caffeine—ABCB1—vagina—ovarian cancer	6.89e-05	0.00117	CbGeAlD
Caffeine—Infection—Epirubicin—ovarian cancer	6.78e-05	0.00115	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—ovarian cancer	6.71e-05	0.00114	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—ovarian cancer	6.7e-05	0.00113	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—ovarian cancer	6.68e-05	0.00113	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—ovarian cancer	6.66e-05	0.00113	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—ovarian cancer	6.63e-05	0.00112	CcSEcCtD
Caffeine—Rash—Docetaxel—ovarian cancer	6.38e-05	0.00108	CcSEcCtD
Caffeine—Dermatitis—Docetaxel—ovarian cancer	6.38e-05	0.00108	CcSEcCtD
Caffeine—Infection—Doxorubicin—ovarian cancer	6.28e-05	0.00106	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—ovarian cancer	6.2e-05	0.00105	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—ovarian cancer	6.17e-05	0.00104	CcSEcCtD
Caffeine—ABCB1—testis—ovarian cancer	6.15e-05	0.00105	CbGeAlD
Caffeine—Skin disorder—Doxorubicin—ovarian cancer	6.14e-05	0.00104	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—ovarian cancer	6.09e-05	0.00103	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—ovarian cancer	5.89e-05	0.000999	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—ovarian cancer	5.63e-05	0.000954	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.45e-05	0.000924	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—ovarian cancer	5.03e-05	0.000852	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—ovarian cancer	4.65e-05	0.000789	CcSEcCtD
Caffeine—ABCB1—lymph node—ovarian cancer	4.46e-05	0.000759	CbGeAlD
Caffeine—Rash—Epirubicin—ovarian cancer	4.3e-05	0.000729	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—ovarian cancer	4.3e-05	0.000729	CcSEcCtD
Caffeine—Rash—Doxorubicin—ovarian cancer	3.98e-05	0.000675	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—ovarian cancer	3.98e-05	0.000674	CcSEcCtD
Caffeine—PIK3CA—Signaling by GPCR—IL6—ovarian cancer	1.95e-06	1.62e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTEN—ovarian cancer	1.94e-06	1.61e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—ovarian cancer	1.94e-06	1.61e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CG—ovarian cancer	1.94e-06	1.61e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.92e-06	1.6e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—ovarian cancer	1.92e-06	1.6e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—AKT1—ovarian cancer	1.92e-06	1.59e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CAV1—ovarian cancer	1.92e-06	1.59e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—AKT1—ovarian cancer	1.92e-06	1.59e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—ovarian cancer	1.91e-06	1.58e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MAPK1—ovarian cancer	1.9e-06	1.58e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—ovarian cancer	1.9e-06	1.58e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—AKT1—ovarian cancer	1.9e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.89e-06	1.57e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PIK3CA—ovarian cancer	1.89e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.89e-06	1.57e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CTNNB1—ovarian cancer	1.89e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.88e-06	1.56e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MAPK1—ovarian cancer	1.88e-06	1.56e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—ovarian cancer	1.88e-06	1.56e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.88e-06	1.56e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—ovarian cancer	1.86e-06	1.54e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MMP9—ovarian cancer	1.85e-06	1.54e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—AKT1—ovarian cancer	1.85e-06	1.53e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.84e-06	1.53e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTEN—ovarian cancer	1.84e-06	1.53e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—ovarian cancer	1.83e-06	1.52e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PIK3CA—ovarian cancer	1.81e-06	1.51e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—AKT1—ovarian cancer	1.8e-06	1.49e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—ovarian cancer	1.79e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	1.78e-06	1.48e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—ERBB2—ovarian cancer	1.78e-06	1.48e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL6—ovarian cancer	1.78e-06	1.48e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—ovarian cancer	1.78e-06	1.47e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—ovarian cancer	1.78e-06	1.47e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.78e-06	1.47e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—FASN—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—STAT3—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MTOR—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CB—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NRAS—ovarian cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.75e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	1.75e-06	1.45e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—ovarian cancer	1.75e-06	1.45e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—STAT3—ovarian cancer	1.74e-06	1.44e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.74e-06	1.44e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—ovarian cancer	1.73e-06	1.44e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—YAP1—ovarian cancer	1.73e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TYMS—ovarian cancer	1.73e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TYMS—ovarian cancer	1.72e-06	1.43e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—ovarian cancer	1.72e-06	1.42e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.71e-06	1.42e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CD—ovarian cancer	1.71e-06	1.41e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL8—ovarian cancer	1.69e-06	1.4e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK3—ovarian cancer	1.68e-06	1.4e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—ovarian cancer	1.68e-06	1.39e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.68e-06	1.39e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—ovarian cancer	1.67e-06	1.39e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—FASN—ovarian cancer	1.66e-06	1.38e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—ovarian cancer	1.66e-06	1.38e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK3—ovarian cancer	1.66e-06	1.38e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—ovarian cancer	1.66e-06	1.37e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1B—ovarian cancer	1.65e-06	1.37e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—FASN—ovarian cancer	1.65e-06	1.37e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PIK3CA—ovarian cancer	1.65e-06	1.37e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—STAT3—ovarian cancer	1.65e-06	1.37e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—ovarian cancer	1.64e-06	1.36e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—ovarian cancer	1.64e-06	1.36e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—ovarian cancer	1.64e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.64e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1.64e-06	1.36e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—ovarian cancer	1.64e-06	1.36e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PIK3CA—ovarian cancer	1.63e-06	1.35e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—ovarian cancer	1.63e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.63e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TYMS—ovarian cancer	1.63e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.62e-06	1.35e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—ovarian cancer	1.62e-06	1.34e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—ovarian cancer	1.62e-06	1.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—ovarian cancer	1.61e-06	1.34e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—ovarian cancer	1.61e-06	1.34e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.61e-06	1.33e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—ovarian cancer	1.61e-06	1.33e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK1—ovarian cancer	1.6e-06	1.33e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—ovarian cancer	1.6e-06	1.33e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—ovarian cancer	1.59e-06	1.32e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK1—ovarian cancer	1.58e-06	1.31e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—ovarian cancer	1.58e-06	1.31e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	1.58e-06	1.31e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—ovarian cancer	1.58e-06	1.31e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—ovarian cancer	1.57e-06	1.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK3—ovarian cancer	1.57e-06	1.3e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.57e-06	1.3e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CTNNB1—ovarian cancer	1.56e-06	1.29e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—ovarian cancer	1.54e-06	1.28e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	1.54e-06	1.28e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.53e-06	1.27e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—ovarian cancer	1.53e-06	1.27e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—ovarian cancer	1.53e-06	1.27e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—ovarian cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—ovarian cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—ovarian cancer	1.51e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.51e-06	1.26e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—ovarian cancer	1.51e-06	1.25e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—ovarian cancer	1.51e-06	1.25e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.5e-06	1.25e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.5e-06	1.25e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK1—ovarian cancer	1.5e-06	1.24e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—ovarian cancer	1.5e-06	1.24e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—ovarian cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TYMS—ovarian cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CB—ovarian cancer	1.49e-06	1.23e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—ovarian cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—ovarian cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—ovarian cancer	1.45e-06	1.2e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.43e-06	1.18e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—ovarian cancer	1.41e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—FASN—ovarian cancer	1.41e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CAV1—ovarian cancer	1.39e-06	1.15e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—ovarian cancer	1.39e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CAV1—ovarian cancer	1.39e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.39e-06	1.15e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—ovarian cancer	1.37e-06	1.14e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—ovarian cancer	1.37e-06	1.14e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—ovarian cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—ovarian cancer	1.36e-06	1.12e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—ovarian cancer	1.35e-06	1.12e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—ovarian cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—ovarian cancer	1.33e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—YAP1—ovarian cancer	1.33e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—ovarian cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CAV1—ovarian cancer	1.31e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.31e-06	1.09e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TYMS—ovarian cancer	1.3e-06	1.08e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK3—ovarian cancer	1.3e-06	1.08e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—ovarian cancer	1.28e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—ovarian cancer	1.28e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.28e-06	1.06e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—ovarian cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—ovarian cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	1.26e-06	1.05e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—ovarian cancer	1.26e-06	1.05e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—ovarian cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.25e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.25e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.24e-06	1.03e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK1—ovarian cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—ovarian cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—ovarian cancer	1.23e-06	1.02e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TYMS—ovarian cancer	1.22e-06	1.02e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—ovarian cancer	1.21e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TYMS—ovarian cancer	1.21e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CAV1—ovarian cancer	1.2e-06	9.98e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—ovarian cancer	1.2e-06	9.97e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CG—ovarian cancer	1.19e-06	9.91e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—ovarian cancer	1.17e-06	9.68e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—ovarian cancer	1.16e-06	9.61e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—ovarian cancer	1.15e-06	9.54e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.15e-06	9.53e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.14e-06	9.44e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—ovarian cancer	1.13e-06	9.41e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.13e-06	9.4e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—ovarian cancer	1.12e-06	9.3e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.11e-06	9.24e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	1.11e-06	9.22e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.1e-06	9.09e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—FASN—ovarian cancer	1.09e-06	9.02e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—ovarian cancer	1.07e-06	8.89e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.07e-06	8.87e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—ovarian cancer	1.06e-06	8.8e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.06e-06	8.77e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CD—ovarian cancer	1.05e-06	8.71e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CAV1—ovarian cancer	1.05e-06	8.69e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMS—ovarian cancer	1.04e-06	8.61e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—ovarian cancer	1.04e-06	8.6e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.03e-06	8.57e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—ovarian cancer	9.92e-07	8.23e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	9.9e-07	8.22e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CAV1—ovarian cancer	9.87e-07	8.19e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CAV1—ovarian cancer	9.79e-07	8.12e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	9.71e-07	8.05e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	9.69e-07	8.04e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	9.63e-07	7.99e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CG—ovarian cancer	9.54e-07	7.92e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—ovarian cancer	9.49e-07	7.88e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.35e-07	7.76e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	9.15e-07	7.59e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—ovarian cancer	9.06e-07	7.52e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	8.99e-07	7.46e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	8.91e-07	7.4e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	8.78e-07	7.29e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—ovarian cancer	8.76e-07	7.27e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	8.39e-07	6.96e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—ovarian cancer	8.39e-07	6.96e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CD—ovarian cancer	8.39e-07	6.96e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—ovarian cancer	8.37e-07	6.95e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CAV1—ovarian cancer	8.36e-07	6.94e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	8.17e-07	6.78e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.15e-07	6.77e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMS—ovarian cancer	8.01e-07	6.64e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.99e-07	6.63e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—ovarian cancer	7.91e-07	6.56e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	7.9e-07	6.56e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	7.84e-07	6.5e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	7.62e-07	6.32e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—ovarian cancer	7.4e-07	6.14e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CB—ovarian cancer	7.31e-07	6.07e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—ovarian cancer	7.25e-07	6.02e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	6.89e-07	5.72e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	6.83e-07	5.67e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	6.7e-07	5.56e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—ovarian cancer	6.67e-07	5.54e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CAV1—ovarian cancer	6.45e-07	5.35e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—ovarian cancer	6.32e-07	5.24e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—ovarian cancer	5.95e-07	4.94e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	5.92e-07	4.91e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	5.91e-07	4.9e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—ovarian cancer	5.9e-07	4.9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.88e-07	4.88e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	5.84e-07	4.84e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	5.58e-07	4.63e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.17e-07	4.29e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	5.12e-07	4.24e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—ovarian cancer	5.04e-07	4.18e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—ovarian cancer	4.83e-07	4.01e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—ovarian cancer	4.82e-07	4e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—ovarian cancer	4.56e-07	3.78e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.5e-07	3.74e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—ovarian cancer	4.46e-07	3.7e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	4.2e-07	3.48e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—ovarian cancer	4.18e-07	3.47e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.16e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—ovarian cancer	3.89e-07	3.23e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—ovarian cancer	3.64e-07	3.02e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.56e-07	2.95e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—ovarian cancer	3.43e-07	2.85e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—ovarian cancer	3.4e-07	2.82e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—ovarian cancer	2.91e-07	2.41e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.75e-07	2.28e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—ovarian cancer	2.24e-07	1.86e-06	CbGpPWpGaD
